96.07
Healthequity Inc stock is traded at $96.07, with a volume of 432.15K.
It is down -2.74% in the last 24 hours and down -8.48% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$98.78
Open:
$97.03
24h Volume:
432.15K
Relative Volume:
0.50
Market Cap:
$8.03B
Revenue:
$1.34B
Net Income/Loss:
$230.70M
P/E Ratio:
35.99
EPS:
2.6695
Net Cash Flow:
$440.96M
1W Performance:
-0.31%
1M Performance:
-8.48%
6M Performance:
+18.39%
1Y Performance:
-1.67%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Wellington Management Group LLP Reduces Position in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity (NASDAQ:HQY) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Yahoo Finance
Raymond James reiterates Strong Buy on HealthEquity stock after earnings beat By Investing.com - Investing.com South Africa
Raymond James reiterates Strong Buy on HealthEquity stock after earnings beat - Investing.com Nigeria
Corient Private Wealth LP Buys New Position in HealthEquity, Inc. $HQY - MarketBeat
B. Metzler seel. Sohn & Co. AG Acquires 25,418 Shares of HealthEquity, Inc. $HQY - MarketBeat
HealthEquity stock gains on strong Q2 2026 results and higher guidance - AD HOC NEWS
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue? - Eastern Progress
Here's Why HealthEquity (HQY) is a Strong Growth Stock - Eastern Progress
HealthEquity’s (HQY) Health Savings Engine Hits A New Gear - Yahoo Finance
Amy Green, Ph.D., Recognized as a 2026 Fierce 50 Health Equity Honoree - Morningstar
Two Sigma Securities LLC Takes Position in HealthEquity, Inc. $HQY - MarketBeat
Legal & General Group Plc Acquires New Shares in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity stock holds after raised guidance and $96.37 open - AD HOC NEWS
HQY Maintained by Deutsche Bank -- Price Target Raised to $142 - GuruFocus
Deutsche Bank Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $142 - Moomoo
80,893 Shares in HealthEquity, Inc. $HQY Acquired by The Manufacturers Life Insurance Company - MarketBeat
Grandeur Peak Global Advisors LLC Sells 31,570 Shares of HealthEquity, Inc. $HQY - MarketBeat
HealthEquity: Adjusted EBITDA Margin Hits Record 48% As HSA Assets Grow 14% To $37.9 Billion - Pulse 2.0
Why HealthEquity Stock Sank This Week - The Globe and Mail
Man Group plc Purchases Shares of 67,560 HealthEquity, Inc. $HQY - MarketBeat
Hsbc Holdings PLC Purchases New Shares in HealthEquity, Inc. $HQY - MarketBeat
Canada Pension Plan Investment Board Makes New Investment in HealthEquity, Inc. $HQY - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 20,332 HealthEquity, Inc. $HQY - MarketBeat
Bridger Management LLC Takes $4.66 Million Position in HealthEquity, Inc. $HQY - MarketBeat
Is It Too Late to Buy HealthEquity Inc (HQY) After 3.2% Rally? G - GuruFocus
HealthEquity (HQY) Could Be 19% Undervalued On Raised Full Year Guidance - Yahoo Finance
HealthEquity Catalysts Intact After Q2 Beat, RBC Says - marketscreener.com
HealthEquity Inc. (HQY) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Citizens reiterates HealthEquity stock rating on strong quarterly results By Investing.com - Investing.com Nigeria
HQY Reiterated by BTIG -- Price Target Maintained at $115 - GuruFocus
Citizens reiterates HealthEquity stock rating on strong quarterly results - Investing.com
Jupiter Topco LLC Invests $78.85 Million in HealthEquity, Inc. $HQY - MarketBeat
Formula Growth Ltd. Purchases New Holdings in HealthEquity, Inc. $HQY - MarketBeat
BTIG Research Reaffirms Buy Rating for HealthEquity (NASDAQ:HQY) - MarketBeat
HQY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fili - GuruFocus
HealthEquity (NASDAQ:HQY) Director Sells 7,632 Shares - MarketBeat
HealthEquity director Adrian Dillon sells $798k in shares - Investing.com India
HealthEquity director Adrian Dillon sells $798k in shares By Investing.com - Investing.com Canada
HealthEquity Inc (HQY) Stock Down 10.6% -- Now Undervalued? GF S - GuruFocus
HealthEquity (NASDAQ: HQY) director sells 7,632 shares in 10b5-1 plan - Stock Titan
HealthEquity, Inc (HQY) Q2 2026 Earnings Call Transcript - AlphaStreet
HealthEquity (NASDAQ:HQY) Shares Gap DownShould You Sell? - MarketBeat
Earnings call transcript: HealthEquity beats Q2 2026 estimates, shares sink 13.6% - Investing.com Nigeria
HealthEquity Shares Fall After Fiscal Q2 Results - marketscreener.com
HealthEquity Reports Q2 2027 Results: Full Earnings Call Transcript - Benzinga
Healthequity Inc earnings beat by $0.05, revenue topped estimates - Investing.com
HQY Looks 0.3% Undervalued on GF Value™ - GuruFocus
Is HealthEquity Inc (HQY) Undervalued After Q2 Earnings Beat? EPS at $0.78, Revenue at $350.7M -- GF Score: 96/100 - GuruFocus
Why is HealthEquity stock sliding today? - Investing.com
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DILLON ADRIAN T | Director |
Aug 25 '26 |
Sale |
104.61 |
7,632 |
798,373 |
62,395 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):